Shuhei Matsumoto
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 02, 2021
In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia.Rio Nakamura, Merime Oota, Shuhei Matsumoto
|Sep 09, 2020
Activities of Cefiderocol with Simulated Human Plasma Concentrations against Carbapenem-Resistant Gram-Negative Bacilli in an In Vitro Chemostat Model.Shuhei Matsumoto, Sachi Kanazawa, Takafumi Sato
|Jul 03, 2019
In Vivo Pharmacodynamic Study of Cefiderocol, a Novel Parenteral Siderophore Cephalosporin, in Murine Thigh and Lung Infection Models.Rio Nakamura, Tsukasa Ito-Horiyama, Miki Takemura
|Oct 25, 2017
In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria.Akinobu Ito, Takafumi Sato, Merime Ota
|Jun 21, 2017
Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics.Shuhei Matsumoto, Christine M Singley, Jennifer Hoover
|Oct 14, 2016
Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa.Akinobu Ito, Toru Nishikawa, Shuhei Matsumoto
Pageof 1
